Statistical comparison among baseline demographic data between treatment group (A) and non-treatment group (B).
| Demographic characteristics . | Total (n = 80) . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | P-value * . |
|---|---|---|---|---|
| Age | 34.35 ± 6.96 | 34.7 ± 6.96 | 33.2 ± 7.02 | 0.3823 |
| Sexual activity | 60 (75%) | 44 (73.3%) | 16 (80%) | 0.7667 |
| Smoking | 23 (28.75%) | 19 (31.7%) | 4 (20%) | 0.4006 |
| Body mass index (kg/m2) | 22.21 ± 2.75 | 22.2 ± 2.76 | 22.2 ± 2.82 | 1.0000 |
| <18.5 | 1 (1.25%) | 1 (1.66%) | 0 (0%) | 1.0000 |
| 18.5–24.9 | 68 (85%) | 50 (83.3%) | 18 (90%) | 0.7203 |
| 25–29.9 | 11 (13.75%) | 9 (15%) | 2 (10%) | 0.7216 |
| Contraceptive use | 49 (61.25%) | 37 (61.7%) | 12 (60%) | 1.0000 |
| Oral | 15 (30.61%) | 10 (27.03%) | 5 (41.67%) | 0.4727 |
| Barrier | 16 (32.65%) | 12 (32.43%) | 4 (33.33%) | 1.0000 |
| Others | 18 (36.74%) | 15 (40.54%) | 3 (25%) | 0.4942 |
| Demographic characteristics . | Total (n = 80) . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | P-value * . |
|---|---|---|---|---|
| Age | 34.35 ± 6.96 | 34.7 ± 6.96 | 33.2 ± 7.02 | 0.3823 |
| Sexual activity | 60 (75%) | 44 (73.3%) | 16 (80%) | 0.7667 |
| Smoking | 23 (28.75%) | 19 (31.7%) | 4 (20%) | 0.4006 |
| Body mass index (kg/m2) | 22.21 ± 2.75 | 22.2 ± 2.76 | 22.2 ± 2.82 | 1.0000 |
| <18.5 | 1 (1.25%) | 1 (1.66%) | 0 (0%) | 1.0000 |
| 18.5–24.9 | 68 (85%) | 50 (83.3%) | 18 (90%) | 0.7203 |
| 25–29.9 | 11 (13.75%) | 9 (15%) | 2 (10%) | 0.7216 |
| Contraceptive use | 49 (61.25%) | 37 (61.7%) | 12 (60%) | 1.0000 |
| Oral | 15 (30.61%) | 10 (27.03%) | 5 (41.67%) | 0.4727 |
| Barrier | 16 (32.65%) | 12 (32.43%) | 4 (33.33%) | 1.0000 |
| Others | 18 (36.74%) | 15 (40.54%) | 3 (25%) | 0.4942 |
Statistical significance at P < 0.05 comparing treatment and non-treatment groups.
Statistical comparison among baseline demographic data between treatment group (A) and non-treatment group (B).
| Demographic characteristics . | Total (n = 80) . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | P-value * . |
|---|---|---|---|---|
| Age | 34.35 ± 6.96 | 34.7 ± 6.96 | 33.2 ± 7.02 | 0.3823 |
| Sexual activity | 60 (75%) | 44 (73.3%) | 16 (80%) | 0.7667 |
| Smoking | 23 (28.75%) | 19 (31.7%) | 4 (20%) | 0.4006 |
| Body mass index (kg/m2) | 22.21 ± 2.75 | 22.2 ± 2.76 | 22.2 ± 2.82 | 1.0000 |
| <18.5 | 1 (1.25%) | 1 (1.66%) | 0 (0%) | 1.0000 |
| 18.5–24.9 | 68 (85%) | 50 (83.3%) | 18 (90%) | 0.7203 |
| 25–29.9 | 11 (13.75%) | 9 (15%) | 2 (10%) | 0.7216 |
| Contraceptive use | 49 (61.25%) | 37 (61.7%) | 12 (60%) | 1.0000 |
| Oral | 15 (30.61%) | 10 (27.03%) | 5 (41.67%) | 0.4727 |
| Barrier | 16 (32.65%) | 12 (32.43%) | 4 (33.33%) | 1.0000 |
| Others | 18 (36.74%) | 15 (40.54%) | 3 (25%) | 0.4942 |
| Demographic characteristics . | Total (n = 80) . | Treatment group (A, n = 60) . | Non-treatment group (B, n = 20) . | P-value * . |
|---|---|---|---|---|
| Age | 34.35 ± 6.96 | 34.7 ± 6.96 | 33.2 ± 7.02 | 0.3823 |
| Sexual activity | 60 (75%) | 44 (73.3%) | 16 (80%) | 0.7667 |
| Smoking | 23 (28.75%) | 19 (31.7%) | 4 (20%) | 0.4006 |
| Body mass index (kg/m2) | 22.21 ± 2.75 | 22.2 ± 2.76 | 22.2 ± 2.82 | 1.0000 |
| <18.5 | 1 (1.25%) | 1 (1.66%) | 0 (0%) | 1.0000 |
| 18.5–24.9 | 68 (85%) | 50 (83.3%) | 18 (90%) | 0.7203 |
| 25–29.9 | 11 (13.75%) | 9 (15%) | 2 (10%) | 0.7216 |
| Contraceptive use | 49 (61.25%) | 37 (61.7%) | 12 (60%) | 1.0000 |
| Oral | 15 (30.61%) | 10 (27.03%) | 5 (41.67%) | 0.4727 |
| Barrier | 16 (32.65%) | 12 (32.43%) | 4 (33.33%) | 1.0000 |
| Others | 18 (36.74%) | 15 (40.54%) | 3 (25%) | 0.4942 |
Statistical significance at P < 0.05 comparing treatment and non-treatment groups.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
